Overview
Modica develops MODICA ADT, an adaptive digital twin that runs hybrid process models alongside bioreactors. It helps biopharmaceutical teams reduce lost batches, accelerate process development, maintain consistent quality and investigate deviations, with modelling services spanning feasibility, qualification and production monitoring.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202425/06/2025
- 202330/06/2024
- 202230/06/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Results vs industry
Industry
Offer
- Bioprocess modelling
- Mechanistic models
- Statistical models
- Machine learning models
- Model qualification
- Model validation
- Model monitoring
Websites
The site is available in: Polish, English, German and French.
- modica.bioMODICA ADT (Adaptive Digital Twin) — ModicaCloudflare
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-04-27.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 23, 2024 | Aid for research and development projects: industrial research | $959K$959,039 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Dec 23, 2024 | Aid for research and development projects: experimental development | $353.5K$353,510 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | R&D activities to develop an innovative, adaptive digital twin (Adaptive Digital Twin - ADT) for modelling biotechnological processes using modular bioreactor hardware components, enabling efficient bioprocess scaling and near-continuous operation | $1.6M$1,644,395 | European Funds for a Modern Economy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Riskbite sp. z o.o. | $399,462.52 | riskbite.com | ||
| NARF sp. z o.o. | $142,888.02 | narf.ai | ||
| Hector Labs sp. z o.o. | $123,526.91 | hectorlabs.io | ||
| 10 Senses sp. z o.o. | $106,578.96 | 10senses.pl | ||
| Dastellar sp. z o.o. | $94,454.17 | dastellar.com | ||
| Simmundi sp. z o.o. | $85,415.15 | simmundi.pl | ||
| Processifier sp. z o.o. | $83,915.91 | processifier.com | ||
| Xenstats sp. z o.o. | $66,774.27 | xenstats.com | ||
| Datomni sp. z o.o. | $27,415.81 | datomni.com | ||
| X-Tour sp. z o.o. | $19,957.31 | x-tour.pl |
FAQ
Last updated: 2026-04-02
